S036 Business and Leadership: What Dermatologists Should Know
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Medicine is one of the largest Businesses in the world. Most medical training does not involve learning about this important topic. In this session, Dermatologists and trainees will learn about various aspects of Business and Leadership in Medicine and Dermatology.
LEARNING OBJECTIVES
Summarize various business aspects of Dermatology and Medicine
Outline various practice settings for Dermatologists and Trainees
Recognize leadership perspectives in AAD and AMA
SCHEDULE
6:00 PM
How to run a successful Medical Dermatology Practice
Amy J McMichael, MD, FAAD
6:14 PM
How to run a successful Surgical/Cosmetic Dermatology Practice
Roy G. Geronemus, MD, FAAD
6:28 PM
How to run a successful Dermatopathology practice
Tammie C. Ferringer, MD, FAAD
6:42 PM
Coding and billing in Medical Dermatology
Dirk Michael Elston, MD, FAAD
6:56 PM
Coding and billing in Surgical Dermatology
Howard Wooding Rogers, MD, PhD, FAAD
7:10 PM
How to Start and Run a Dermatology Solo Practice
Suzanne McGoey, MD, MPH, FAAD
7:24 PM
How to run a successful Pediatric Dermatology practice
Fernanda Bellodi Schmidt, MD
7:38 PM
How to Run a Successful Dermatology Organization
Mark D. Kaufmann, MD, FAAD
7:52 PM
Teledermatology
George Han, MD, PhD, FAAD
8:06 PM
AI in Dermatology
Faranak Kamangar, MD, FAAD
8:20 PM
Physician Leadership: Perspectives from a former AMA President
Jack S. Resneck Jr., MD, FAAD
8:34 PM
How to get more involved with AAD Leadership
Marta Jane Van Beek, MD, MPH, FAAD
8:48 PM
Q&A
SPEAKERS
Fernanda Bellodi Schmidt, MD
Dirk Michael Elston, MD, FAAD
Tammie C. Ferringer, MD, FAAD
Roy G. Geronemus, MD, FAAD
George Han, MD, PhD, FAAD
Faranak Kamangar, MD, FAAD
Mark D. Kaufmann, MD, FAAD
Suzanne McGoey, MD, MPH, FAAD
Amy J McMichael, MD, FAAD
Keyvan Nouri, MBA, MD, FAAD
Jack S. Resneck Jr., MD, FAAD
Howard Wooding Rogers, MD, PhD, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Fernanda Bellodi Schmidt, MD
Abeona Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding);
Dirk Michael Elston, MD, FAAD
No financial relationships exist with ineligible companies.
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
Roy G. Geronemus, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);
George Han, MD, PhD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Celgene – Investigator(Grants/Research Funding); DermTech Inc. – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Hikma Pharmaceuticals – Speaker/Faculty Education(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); MC2 Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Othro Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sonoma Pharmaceuticals – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); UCB – Advisory Board(Honoraria);
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Mark D. Kaufmann, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Incyte – Consultant (1099 relationship)(Fees); MoleSafe, Inc. – Other(Stock); Novartis – Consultant (1099 relationship)(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees);
Suzanne McGoey, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Jack S. Resneck Jr., MD, FAAD
No financial relationships exist with ineligible companies.
Howard Wooding Rogers, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.